Principal Financial Group Inc Accelerate Diagnostics, Inc Transaction History

Principal Financial Group Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 09, 2022	SELL	$4.27 - $6.97 $185,480 - $302,762	-43,438 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$5.31 - $8.25 $11,384 - $17,688	-2,144 Reduced 4.7%	43,438 $253,000
Q2 2021 Aug 10, 2021	BUY	$6.81 - $9.23 $9,894 - $13,411	1,453 Added 3.29%	45,582 $367,000
Q1 2021 May 10, 2021	BUY	$7.99 - $15.0 $26,359 - $49,485	3,299 Added 8.08%	44,129 $367,000
Q4 2020 Feb 08, 2021	BUY	$7.04 - $11.7 $208,538 - $346,577	29,622 Added 264.29%	40,830 $309,000
Q3 2020 Nov 06, 2020	SELL	$9.98 - $18.04 $5,489 - $9,922	-550 Reduced 4.68%	11,208 $119,000
Q2 2020 Aug 05, 2020	BUY	$7.49 - $15.16 $19,121 - $38,703	2,553 Added 27.73%	11,758 $178,000
Q1 2018 May 14, 2018	BUY	$22.55 - $29.9 $20,543 - $27,238	911 Added 10.98%	9,205 $210,000
Q4 2017 Feb 13, 2018	BUY	$18.0 - $30.0 $149,292 - $248,820	8,294	8,294 $217,000

549K

Ticker AXDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 99,059,904
Market Cap $113M
Description
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Principal Financial Group Inc with notifications on news.